Fulranumab
Fulranumab is a human IgG2 monoclonal antibody against nerve growth factor (NGF) and can be used for the research of pain[1].
Product Specifications
CAS Number
902141-80-4
UNSPSC
12352203
Target
Trk Receptor
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/fulranumab.html
Purity
96.74
Solubility
10 mM in DMSO
Smiles
[Fulranumab]
Molecular Weight
(145.37 kDa)
References & Citations
[1]Dai S, et al. Development of a method that eliminates false-positive results due to nerve growth factor interference in the assessment of fulranumab immunogenicity. AAPS J. 2014 May;16 (3) :464-77.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6309777-01 0.1 mL
IKKB, Phosphorylated (S705) (IKBKB, IKKB, Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B kinase 2, Nuclear factor NF-kappa-B inhibitor kinase beta) (MaxLight 405)
Sign In for Pricing
View Details MBS6309777-02 5x 0.1 mL
IKKB, Phosphorylated (S705) (IKBKB, IKKB, Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B kinase 2, Nuclear factor NF-kappa-B inhibitor kinase beta) (MaxLight 405)
Sign In for Pricing
View Details